Kenvue Inc. (NYSE:KVUE) Shares Sold by Alpine Woods Capital Investors LLC

Alpine Woods Capital Investors LLC reduced its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 14.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 262,125 shares of the company's stock after selling 46,040 shares during the quarter. Kenvue comprises approximately 1.6% of Alpine Woods Capital Investors LLC's portfolio, making the stock its 15th biggest holding. Alpine Woods Capital Investors LLC's holdings in Kenvue were worth $6,286,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also made changes to their positions in the company. Continuum Advisory LLC boosted its stake in shares of Kenvue by 2,071.1% during the 1st quarter. Continuum Advisory LLC now owns 1,954 shares of the company's stock worth $47,000 after purchasing an additional 1,864 shares during the last quarter. Clarity Asset Management Inc. purchased a new position in shares of Kenvue during the fourth quarter valued at approximately $45,000. Rossby Financial LCC purchased a new position in shares of Kenvue during the first quarter valued at approximately $52,000. Golden State Wealth Management LLC boosted its position in Kenvue by 292.0% during the first quarter. Golden State Wealth Management LLC now owns 3,081 shares of the company's stock worth $74,000 after acquiring an additional 2,295 shares during the last quarter. Finally, Versant Capital Management Inc grew its stake in Kenvue by 77.9% in the 1st quarter. Versant Capital Management Inc now owns 3,415 shares of the company's stock worth $82,000 after acquiring an additional 1,495 shares during the period. Institutional investors and hedge funds own 97.64% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on KVUE shares. Evercore ISI initiated coverage on Kenvue in a research note on Monday, March 24th. They set an "in-line" rating and a $25.00 price target on the stock. Citigroup reiterated a "neutral" rating on shares of Kenvue in a research report on Friday, June 13th. Redburn Atlantic started coverage on Kenvue in a report on Thursday, April 10th. They issued a "neutral" rating and a $23.50 price target for the company. Barclays increased their price objective on shares of Kenvue from $22.00 to $23.00 and gave the stock an "equal weight" rating in a report on Monday, May 12th. Finally, UBS Group boosted their target price on shares of Kenvue from $24.00 to $25.00 and gave the company a "neutral" rating in a report on Friday, May 9th. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $25.33.

Kenvue Stock Up 2.1%

NYSE KVUE traded up $0.43 during trading hours on Friday, hitting $21.35. The company had a trading volume of 25,967,559 shares, compared to its average volume of 16,055,380. The firm's 50 day moving average is $22.34 and its 200 day moving average is $22.29. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.86 and a quick ratio of 0.60. Kenvue Inc. has a fifty-two week low of $17.85 and a fifty-two week high of $25.17. The company has a market capitalization of $40.96 billion, a price-to-earnings ratio of 38.82, a P/E/G ratio of 3.25 and a beta of 0.83.

Kenvue (NYSE:KVUE - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. The business had revenue of $3.74 billion during the quarter, compared to analyst estimates of $3.69 billion. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. The company's revenue for the quarter was down 3.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.28 earnings per share. Sell-side analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th were paid a dividend of $0.205 per share. The ex-dividend date was Wednesday, May 14th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.84%. Kenvue's dividend payout ratio is currently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.